Patients with obstructive airways disease are not usually candidates for intravenous atenolol therapy.
Contact lens wearers should be informed about the possible reduction of lacrimation on atenolol therapy.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.